Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

Anticancer drug utilizing Trans-splicing Ribozyme technology <li /> Second Fast Track Designation following brain cancer approval < ...

The study, led by researchers from the INSERM, the French National Institute of Health and Medical Research, focused on ...

Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...